APPOINTMENT : Alain Puisieux, new director of Institut Curie Research Center
"I have long-standing scientific ties with several researchers from Institut Curie, and I am delighted to be joining this wonderful institute", explains Prof. Alain Puisieux.
A specialist in cell plasticity processes during the early stages of tumorigenesis, he is the author of more than 150 publications in international journals such as Cancer Cell, Nature, Nature Cell Biology, Nature Genetics and Nature Medicine.
His work has also earned him various prestigious awards and honors, such as his appointment to France’s National Academy of Medicine, National Academy of Pharmacy and the University Institute of France.
Alain Puisieux is familiar with Institut Curie since, in addition to completing his biology internship at Institut Curie in the late 1980s, he has been a member of the Research Center’s Scientific Commission since 2013. After receiving his doctorate in Boston (Massachusetts General Hospital, Harvard Medical School, USA), he joined the Leon-Berard Center (CLB), a cancer center in Lyon, as a postdoctoral fellow and then as a hospital practitioner biologist. Appointed as a professor of the University in 2000 (University Lyon 1), in Lyon he created the Inserm 590 Oncogenesis and Tumor Progression Unit, and the Cancer Research Center in Lyon (UMR Inserm 1052 - CNRS 5286 - UCBL - CLB), now composed of 26 research teams and 500 members, which he led from 2011 to 2019.
His project is centered around four major goals:
- to boost the center's excellence in basic research in the field of life sciences, based on the notions of inter-disciplinarity, curiosity and freedom
- to develop translational research and stimulate innovation within the context of the Comprehensive Cancer Center
- to offer an infrastructure to researchers
- to interact with the environment and promote the Institut Curie model
"Alain Puisieux is an extremely qualified candidate. His excellence is recognized at the national and international level, and we are excited at the prospect of his talent and skills being put to work in research at Institut Curie," enthuses Prof. Thierry Philip, Chairman of the Executive Board of Institut Curie.
Institut Curie is excited to welcome him this fall; his experience as head of a research center affiliated with a cancer center, his knowledge of the organization of academic research in France, and his own scientific expertise which is very consistent with the Research Center's own research areas, will be major assets as he takes up the position.
The Executive Board, with the Ministry of Research’s assent and following approval from the Supervisory Board, the International Scientific Advisory Board of the institute and the Scientific Commission of the Research Center, appointed him Director of Research for a five-year term, renewable once, from September 1, 2019. As a reminder, in accordance with the institute's statutes, a selection committee chaired by Prof. Alain Fischer, a member of the Scientific Advisory Board, was set up in August 2018 to choose Geneviève Almouzni’s successor.
About Institut Curie
Institut Curie, France’s leading center in the fight against cancer, combines an internationally-renowned research center with a cutting-edge hospital group, which treats all types of cancer, including the rarest. Founded in 1909 by Marie Curie, Institut Curie employs 3,400 researchers, physicians and caregivers across three sites (Paris, Saint-Cloud and Orsay), working on its three missions, namely treatment, research and teaching. A private foundation with public utility status, Institut Curie is authorized to receive donations and legacies, and thanks to the support of its donors, is able to make discoveries more quickly, improving treatments and quality of life for patients.
Find out more at curie.fr